HOME JOURNALS CONTACT

International Journal of Pharmacology

Year: 2006 | Volume: 2 | Issue: 1 | Page No.: 15-19
DOI: 10.3923/ijp.2006.15.19
Influx and Efflux of Glutathione During Continuous Pain Induction in Rat Hepatocytes and Glial Cells
Jalal Pourahmad, Niloofar Rezvani, Mohsen Rezaei and Abolhasan Ahmadiani

Abstract: In this study we examined the intra and extracellular glutathione levels in both glial cells and hepatocytes of rats during continuous pain induction. Animals were divided in 4 groups; one day, four day and seven day pain groups vs. control group. Results showed that the maximum generation of ROS occurs in four day group of continuous pain induction in both glia and hepatocytes of rats. The intracellular GSH was at highest level in one day pain group due to GSH influx and synthesis as two defensive mechanisms against oxidative stress in both glia and hepatocytes. In hepatocytes, however, by considering the levels of extracellular GSSG in one day pain group, it seems that the enzymatic function of GSSG reductase is also another important defense mechanism in the first group of continuous pain induction. Maximum extra cellular GSSG was in 7 day pain group in both glia and hepatocytes. Results suggest that following continuous pain induction, oxidative stress is the major cause for GSH depletion in both glia and hepatocytes and leads cells to the later consequences including apoptosis.

Fulltext PDF Fulltext HTML

How to cite this article
Jalal Pourahmad, Niloofar Rezvani, Mohsen Rezaei and Abolhasan Ahmadiani, 2006. Influx and Efflux of Glutathione During Continuous Pain Induction in Rat Hepatocytes and Glial Cells. International Journal of Pharmacology, 2: 15-19.

Keywords: rat, apoptosis, glutathione, reactive oxygen species and Inplammatory pain

INTRODUCTION

Subcutaneous (s.c.) injection of dilute formalin into a hind paw induces a rapid and prolonged hyperalgesia across widespread areas of the body. This s.c. chemical irritant activates peripheral nerves leading to activation of dorsal horn neuron[1-3].

Glial cells (astrocytes and microglia) in the brain and spinal cord have been recognized as active participants in the creation and maintenance of continuous pain induced by inflammation, damage to peripheral tissues, peripheral nerves, spinal nerves and the spinal cord. On activation, this glia express characteristics quite similar to immune cells, in which they respond to viruses and bacteria, releasing pro-inflammatory cytokines which create pathological pain[4,5].

This CNS glia also becomes activated by certain sensory signals arriving from the periphery, leading to release of pro-inflammatory cytokines. To date, most evidence has supported a putative role for the glial pro-inflammatory cytokines, tumor necrosis factor (TNF-α), interlukin-1 (IL-1) and IL-6[6,7].

Proinflammatory cytokines are classically known as a family of proteins released by activated immune cells. It is an important feature that the effects of proinflammatory cytokines will be synergized (especially TNF-α and IL-1) if released together, that more powerful effects are observed when more than one cytokine is present. TNF-α and IL-1 in particular are very potent biological molecules, producing large effects when administered in the CNS in the femptogram to picogram range[6,8,9].

Following activation, glia cause pain transmission neuron hyperexcitability and the exaggerated release of substance P and EAAs (excitatory amino acids) from presynaptic terminals. These changes are created by the glial release of NO, EAAs, ROS (Reactive Oxygen Species), PGs (prostaglandins), pro-inflammatory cytokines (for example IL-1, IL-6 and TNF-α) and NGF (nerve growth factor)[7-9].

This massive release of proinflammatory cytokines could induce some levels of damage to the neighboring neurons and glial cells in the brain and spinal cord. There is therefore more to investigate the molecular and pathological mechanisms involved in the continuous pain induced brain, spinal cord or liver injury.

Hepatocytes express and release inflammatory mediators after challenge with proinflammatory cytokines released by the glial cells during the inflammatory pain. Nitric oxide synthase-2 (NOS-2) is expressed under these conditions and the high-output NO synthesis that follows, contributes to the inflammatory response in this tissue and can be a cause for several hepatopathies[10].

Glutathione (GSH) is a ubiquitous essential tripeptide that protects cells against oxidants, electrophilic compounds and xenobiotics. It is a key intracellular reducing agent and is implicated in immune modulation and inflammatory conditions.

Proinflammatory cytokines especially TNF-α induce oxidative stress by the generation of ROS via leakage from the mitochondria electron transport chain associated with an increase in a variety of defense mechanisms including antioxidants. These inflammatory events lead to GSH depletion and increasing of oxidized GSH (GSSG)[8,11,12].

The purpose of this study was to examine the reduced and oxidized glutathione levels of glial cells and hepatocytes during continuous inflammatory pain in rats, as a marker for determination of pain induced brain or liver damage.

MATERIALS AND METHODS

Animals: Male wistar rats (200-300 g) were used in the present study. All rats were housed in a room at a constant temperature of 25°C on a 12/12 h light/dark cycle with food and water available ad libitum. All experiments were conducted according to protocols approved by the Committee of Animal Experimentation of Shaheed Beheshti University of Medical Sciences, Tehran, Iran. This study was performed in Faculty of Pharmacy, Shaheed Beheshti University of Medical Sciences from September 2003 to September 2004.

Pain induction and grouping: A subcutaneous (s.c) injection of 50 μL of 5% formalin in to one hind paw was used for induction of continuous pain[1,3].

Animals were grouped as:

Animals suffered inflammatory pain for 1 day. This group received a single injection in to a one side of hind paw.
Animals suffered inflammatory pain for 4 days. For this group, the procedure mentioned for group one was repeated for 4 consecutive days and every day, the formalin injection was given in to a different paw site (day 1: right/dorsal, day 2: left/ventral, day 3: right/ventral, day 4: left/dorsal).
Animals suffered inflammatory pain for 7 days. In this group, the same procedure was carried out 4 times on each side of hind paws but a day interval was considered for each injection.

Cell preparation
Freshly prepared hepatocytes:
Hepatocytes were isolated from adult male wistar rats by collagenase perfusion of the liver as described by Pourahmad and O'Brien[13]. Cell viability was measured by Trypan blue exclusion method and the viability considered in this study was at least 85-90%.

Glial cells: Glial cells were prepared from hippocampus of wistar rats adapted from Dermietzel et al.[14]. In brief after removal of hippocampus it was collected in Phosphate Buffered Saline (PBS) with pH 7 and afterward transferred to trypsin-EDTA(0.1%) and dissected to small parts, incubated in 37°C for 10 min.

After cell dissociation, DMEM medium was added and passed through a 70 and 25 μm nylon mesh.

GSH and GSSG assessment: GSH and GSSG were determined according to the spectrofluorimetric method[15]. Each sample was measured in quartz cuvettes using a fluorimeter set at 350 nm excitation and 420 nm emission.

Determination of ROS: To determine the amount of ROS generation, 2',7'-dichlorofluorescin diacetate was used as it penetrates the cells and becomes hydrolyzed by an intracellular esterase to form DCFH. The latter reacts with intracellular ROS to form the highly fluorescent 2',7'-dichlorofluorescin, which effluxes the cell. The fluorescence intensity of the 2',7'-dichlorofluorescin formed was determined at 540 nm (emission) and at 470 nm (excitation)[16].

Statistical analysis: Data were analysed using one-way analysis of variance (ANOVA) and Levene’s test for homogeneity of variances. Results represent the mean±SD of triplicate samples. The minimal level of significance chosen was p=0.001[17].

RESULTS

As shown in Table 1 and 2, pain stress significantly (p=0.001) depleted hepatocytes and glial cells intracellular GSH in 4 and 7 day pain groups comparing to the corresponding control groups. In 1 day pain group, GSH level however was significantly raised in both hepatocytes and glia. Pain stress lowered the glial cells extracellular GSH levels in all groups. On the other hand, in hepatocytes, extracellular GSH levels only showed significant increase (p=0.001) in 1 day pain group comparing to control, 4 and 7 day pain groups (Table 1).

Table 1: Intra and extracellular levels of reduced and oxidized glutathione of hepatocytes in different pain groups of rats

Table 2: Intra and extracellular levels of reduced and oxidized glutathione of glia in different pain groups of rats

GSSG levels were significantly (p=0.001) increased in both cell types following the pain induction. Only in the 7 day pain group, the hepatocytes intracellular GSSG levels were significantly lower than that of the 4 day pain group (Table 1 and 2).

The extracellular GSSG levels in both glia and hepatocytes in 4 and 7 day pain groups were significantly (p=0.001) higher than those of corresponding control groups (Table 1 and 2). Although the extracellular GSSG levels in glial cells of 1 day pain group were significantly (p=0.001) higher than that of control group but there was a significant decrease in the extracellular GSSG levels in hepatocytes of 1 day pain group comparing to its control (Table 1 and 2).The order of extracellular GSSG increase in different groups was as follows:

In glial cells: 7 day group >4 day group >1 day group > control
In hepatocytes: 7 day group >4 day group > control >1 day group

Figure 1 shows the comparative levels of ROS formation in glia and hepatocytes of control and three different pain groups. The increase in ROS generation was demonstrated as fold(s) to ROS levels by the corresponding control group. There was a significant increase in ROS formation of both glia and hepatocytes following the pain induction in 1 and 4 day pain groups.

Fig. 1: Demonstrates comparative levels of Reactive Oxygen Species formation in glia and hepatocytesgroups. All groups were significantly different (p=0.001) from each other except for (1 vs. 7 day groups) in both cell types; ANOVA followed by Tukey test

However, ROS formation was significantly lower in 7 day pain group comparing to 4 day pain group.

DISCUSSION

The GSH redox system is crucial in maintaining intracellular GSH homeostasis, which is critical to normal cellular physiological process and represents one of the most important antioxidant defense systems in the body. This system uses GSH as a substrate in the detoxification of peroxides such as hydrogen peroxide (H2O2) and lipid peroxides, a reaction that involves glutathione peroxidase (GPx). This reaction generates oxidized GSH (GSSG), which is subsequently reduced by GSSG reductase in a reaction that requires the hexose monophosphate shunt pathway producing NADPH. Physiologically the GSSG reductase reaction is driven strongly in favor of GSH, with the GSH to GSSG ratio normally more than 90%[8,18].

In the present study it is investigated that the inflammatory pain induced intracellular GSH alterations and ROS generation in the rat brain glial cells and hepatocytes. Results showed the intracellular GSH levels were significantly increased in both glial cells and hepatocytes in the one day pain group (Table 1 and 2). On the other hand the intracellular ROS formation was also significantly increased in the both hepatocytes and glial cells of all rats of the one day pain group comparing to control group (Fig. 1), it suggest that oxidative stress or in other word, ROS formation is rapidly started following the inflammatory pain induction in both brain and liver cells. It is also suggested from results that the intracellular defense mechanism including GSH synthesis[19] and GSH influx[20,21] and also GSSG reduction to GSH by GSSG reductase[8], are reflectively activated following the pain induction.

Since the extracellular GSSG contents were significantly decreased in all rats of one day pain group we therefore suggest that the enzymatic function of GSSG reductase is the major defense mechanism in the first day following the inflammatory pain induction in the hepatocytes. Then the reduced GSH could influx the cell to cope with ROS formation and oxidative stress. On the other hand, the increase in GSH synthesis and also influx, are the major defense mechanisms in the brain glial cells following the inflammatory pain induction (Table 1 and 2). Two cytosolic enzymes, γ-glutamylcysteine synthetase (γ-GCS) and GSH synthetase (GS), are involved in GSH synthesis. γ-GCS catalyses the rate limiting state in the GSH synthesis[18]. In the physiologic conditions, about the 80% of γ-GCS is inactive due to binding to GSH. In the oxidative stress condition, the enzyme is released from GSH bound and then be activated[8,18]. The GSH synthesis will therefore be considerably increased. This defensive process is one of the ways that a normal cell copes with the oxidative stress and compensates its depleted GSH. Besides it is now clear that under the oxidative stress condition the γ-GCS mRNA will be upregulated. It has already been reported that the intracellular GSH, was significantly increased in 24 h following the oxidative stress induction on the lung alveolar epithelial cells[18,22]. This result is similar to the results of one day pain group. Results also showed (Table 1 and 2) in all rats of 1 day pain group that the intracellular GSSG contents were significantly increased and then transferred to extracellular fluid using the known membrane channels[23], suggesting that the ROS formation induced was responsible for GSH oxidation.

Maximum intracellular ROS formation in this study was reported in both rat hepatocytes and glial cells of 4 day pain group (Fig. 1), suggesting that pick of oxidative stress following the continuous pain induction could be occurred in the 4th day. Obviously activation of different defense mechanisms could then justify decrease in intracellular ROS formation in both rat hepatocytes and glial cells of 7 day pain group.

REFERENCES

  • Vaccarino, A.L. and L.C. Jr. Couret , 1995. Relationship between hypothalamic-pituitary-adrenal activity and blockade of tolerance to morphine analgesia by pain: A strain comparison. Pain, 63: 385-389.
    Direct Link    


  • Watkins, L.R., D. Martin, P. Ulrich, K.J. Tracey and S.F. Maier, 1997. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain, 71: 225-235.
    Direct Link    


  • Okuda, K., C. Sakurada, M. Takahashi, T. Yamada and T. Sakurada, 2001. Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats. Pain, 92: 107-115.
    Direct Link    


  • Viviani, B., E. Corsini, C.L. Galli and M. Marinovich, 1998. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-α. Toxicol. Applied Pharmacol., 150: 271-276.
    Direct Link    


  • Watkins, L.R., E.D. Milligan and S.F. Maier, 2001. Spinal cord glia: New players in pain. Pain, 93: 201-205.
    Direct Link    


  • Watkins, L.R., E.D. Milligan and S.F. Maier, 2001. Glial activation: A driving force for pathological pain. Trends Neurosci., 24: 450-455.
    CrossRef    PubMed    Direct Link    


  • Watkins, L.R. and S.F. Maier, 2002. Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev., 82: 981-1011.
    Direct Link    


  • Rahman, I. and W. Macnee, 1999. Lung glutathione and oxidative stress: Implications in cigarette smoke-induced airway disease. Am. J. Physiol., 277: L1067-L1088.
    Direct Link    


  • Watkins, L.R. and S.F. Maier, 2003. Glia: A novel drug discovery target for clinical pain. Natl. Rev. Drug Discov., 2: 973-985.
    Direct Link    


  • Martin-Sanz, P., S. Hortelano, N.A. Callejas, N. Goren, M. Casado, M. Zeini and L. Bosca, 2002. Nitric oxide in liver inflammation and regeneration. Metab. Brain Dis., 17: 325-334.
    Direct Link    


  • Di Monte, D.A., P. Chan and M.S. Sandy, 1992. Glutathione in Parkinsons disease: A link between oxidative stress and mitochondrial damage. Ann. Neurol., 32: 111-115.
    Direct Link    


  • Heales, S.J.R., J.P. Bolanos, V.C. Stewart, P.S. Brookes, J.M. Land and J.B. Clark, 1999. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta, 1410: 215-228.
    Direct Link    


  • Pourahmad, J. and P.J. O'Brien, 2000. A comparison of hepatocyte cytotoxic mechanisms for Cu2+ and Cd2+. Toxicology, 143: 263-273.
    CrossRef    PubMed    Direct Link    


  • Dermietzel, R., E.L. Hertzberg, J.A. Kessler and D.C. Spray, 1991. Gap junctions between cultured astrocytes: Immunocytochemical, molecular and electrophysiological analysis. J. Neurosci., 11: 1421-1432.
    Direct Link    


  • Hissin, P.J. and R. Hilf, 1976. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem., 74: 214-226.
    CrossRef    PubMed    Direct Link    


  • Shen, H.M., C.Y. Shi, Y. Shen and C.N. Ong, 1996. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free. Radic. Biol. Med., 21: 139-146.
    Direct Link    


  • Lykkesfeldt, J., T.M. Hagen, V. Vinarsky and B.N. Ames, 1998. Age-associated decline in ascorbic acid concentration, recycling and biosynthesis in rat hepatocytes-reversal with (R)-α -lipoic acid supplementation. FASEB J., 12: 1183-1189.
    Direct Link    


  • Cantin, A.M. and R. Begin, 1991. Glutathione and inflammatory disorders of the lung. Lung, 169: 123-138.
    CrossRef    Direct Link    


  • Rahman, I., M.F. Lawson, C.A.D. Smith, D.J. Harrison and W. MacNee, 1996. Induction of γ-glutamylcycteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells. FEBS Lett., 396: 21-25.
    Direct Link    


  • Lu, S.C., W.M. Sun, J. Yi, M. Ookhtens, G. Sze and N. Kaplowitz, 1996. Role of two recently cloned rat liver GSH transporters in the ubiquitous transport of GSH in mammalian cells. J. Clin. Invest., 97: 1488-1496.
    Direct Link    


  • Iantomasi, T., F. Favilli, P. Marraccini, T. Magaldi, P. Bruni and M.T. Vincenzini, 1997. Glutathione transport system in human small intestine epithelial cells. Biochim. Biophys. Acta, 1330: 274-283.
    Direct Link    


  • Deneke, S.M., S.N. Gershoff and B.L. Fanburg, 1983. Potentiation of oxygen toxicity in rats by dietary protein or amino acid deficiency. J. Applied Physiol., 54: 147-151.
    Direct Link    


  • Khan, S. and P.J. O'Brien, 1997. Rapid and specific efflux of glutathione before hepatocyte injury induced by hypoxia. Biochem. Biophys. Res. Commun., 238: 320-322.
    CrossRef    

  • © Science Alert. All Rights Reserved